Key Takeaways Expanding into new procedures and markets holds promise, but execution risks and payer preferences for non-surgical solutions may curb sustainable growth. Dependence on a limited product line raises vulnerability to competitor disruption, while sustained investment needs could restrict profitability improvements.Read more
Key Takeaways Accelerated physician adoption, international expansion, and strong innovation pipeline position SI-BONE for much faster revenue and margin growth than current expectations. Aging demographics, superior training programs, and operational efficiencies will drive sustained demand, increased procedure volumes, and expanding market share.Read more
Key Takeaways Accelerating physician adoption and regulatory wins are expanding procedure access, driving robust growth across both domestic and international markets. Diversifying the product lineup and gaining positive reimbursement trends are enhancing profitability prospects and supporting long-term margin expansion.Read more
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
